131 related articles for article (PubMed ID: 36166182)
1. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease.
Wen Q; Xu ZL; Wang Y; Lv M; Song Y; Lyv ZS; Xing T; Xu LP; Zhang XH; Huang XJ; Kong Y
Sci China Life Sci; 2023 Mar; 66(3):528-544. PubMed ID: 36166182
[TBL] [Abstract][Full Text] [Related]
2. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
3. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.
Gao J; Xu Y; Ma S; Liang Y; Liu C; Shen J; Sun Z; Niu M; Xu K; Pan B
Transplant Cell Ther; 2022 Mar; 28(3):134.e1-134.e10. PubMed ID: 34896653
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
6. R707, a fully human antibody directed against CC-chemokine receptor 7, attenuates xenogeneic acute graft-versus-host disease.
Fowler KA; Vasilieva V; Ivanova E; Rimkevich O; Sokolov A; Abbasova S; Kim E; Coghill JM
Am J Transplant; 2019 Jul; 19(7):1941-1954. PubMed ID: 30748092
[TBL] [Abstract][Full Text] [Related]
7. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
8. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
Front Immunol; 2020; 11():593321. PubMed ID: 33584657
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ruxolitinib combined with glucocorticoid on cytomegalovirus activation in acute graft-versus-host disease].
Xing SY; Qian K; Zhao YX; Peng B; Yang JJ; Dou LP; Liu DH
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):732-737. PubMed ID: 36709166
[No Abstract] [Full Text] [Related]
10. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
11. Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.
Song Q; Nasri U; Zeng D
Front Immunol; 2022; 13():844271. PubMed ID: 35251043
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
13. Association between CD34
Yao D; Li B; Chu X; Pan J; Meng L; Hu Y; Gao L; Li J; Tian Y; Hu S
Transpl Immunol; 2023 Apr; 77():101779. PubMed ID: 36596428
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
16. PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Snyder KJ; Zitzer NC; Gao Y; Choe HK; Sell NE; Neidemire-Colley L; Ignaci A; Kale C; Devine RD; Abad MG; Pietrzak M; Wang M; Lin H; Zhang YW; Behbehani GK; Jackman JE; Garzon R; Vaddi K; Baiocchi RA; Ranganathan P
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32191634
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Wang Z; Ma K; Liu C; Hu X; Que W; Ito H; Takahashi K; Nakajima M; Tanaka T; Ren K; Guo WZ; Yi SQ; Li XK
Drug Discov Ther; 2021 Jan; 14(6):304-312. PubMed ID: 33390570
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid resistance of allogeneic T cells alters the gene expression profile in the inflamed small intestine of mice suffering from acute graft-versus-host disease.
Li H; Kaiser TK; Borschiwer M; Bohnenberger H; Reichardt SD; Lühder F; Walter L; Dressel R; Meijsing SH; Reichardt HM
J Steroid Biochem Mol Biol; 2019 Dec; 195():105485. PubMed ID: 31561002
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Matrix-associated Protein SMAR1 Attenuated Acute Graft-versus-host Disease by Targeting JAK-STAT Signaling in CD4 + T Cells.
Huang Z; Zhang R; Teng Y; Guo J; Zhang H; Wang L; Tang LV; Shi W; Wu Q; Xia L
Transplantation; 2024 Mar; 108(3):e23-e35. PubMed ID: 37817309
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose 5-Aza and DZnep Alleviate Acute Graft-
Wang QY; Liu HH; Dong YJ; Liang ZY; Yin Y; Liu W; Wang QY; Wang Q; Sun YH; Xu WL; Han N; Li Y; Ren HY
Front Immunol; 2022; 13():780708. PubMed ID: 35281001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
